All Access Articles |
- Cartesian Therapeutics Receives FDA Agreement for Phase 3 Trial in Myasthenia Gravis | 2025-01-27 | PHARMACEUTICAL
- Cartesian Therapeutics Reports Positive Phase 2b Trial Results | 2024-12-03 | PHARMACEUTICAL
- Cartesian Therapeutics – FDA Grants RMAT Designation for Descartes-08 | 2024-05-22 | UNITED STATES